8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one
C30H24N6O — CID 152976896
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one
8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one (PubChem CID 152976896) has the molecular formula C30H24N6O and a molecular weight of 484.56 g/mol. Its IUPAC name is 8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one.
Molecular Properties
| Compound Name | 8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one |
|---|---|
| PubChem CID | 152976896 |
| Molecular Formula | C30H24N6O |
| Molecular Weight | 484.56 g/mol |
| Exact Mass | 484.20 |
| IUPAC Name | 8-(2-methylpyrimidin-5-yl)-2-phenyl-3-[(2R)-1-pyrido[3,2-d]pyrimidin-4-ylpropan-2-yl]isoquinolin-1-one |
| SMILES | Cc1ncc(-c2cccc3cc([C@H](C)Cc4ncnc5cccnc45)n(-c4ccccc4)c(=O)c23)cn1 |
| InChI | InChI=1S/C30H24N6O/c1-19(14-26-29-25(34-18-35-26)12-7-13-31-29)27-15-21-8-6-11-24(22-16-32-20(2)33-17-22)28(21)30(37)36(27)23-9-4-3-5-10-23/h3-13,15-19H,14H2,1-2H3/t19-/m1/s1 |
| InChIKey | UTPCBSAKXBSCHK-LJQANCHMSA-N |
| XLogP | 5.44 |
| TPSA | 86.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.56 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152976896 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.